All Pharma News
price-trendAsk Us
twoXAR Presents Preclinical Data Demonstrating Positive Safety and Tolerability

twoXAR Presents Preclinical Data Demonstrating Positive Safety and Tolerability
PRNEWSWIRE
13 Nov 2020
Share Share
twoXAR Pharma Presents Positive Preclinical Safety and Efficacy Data TXR-311

twoXAR Pharma Presents Positive Preclinical Safety and Efficacy Data TXR-311
PRNEWSWIRE
22 Jun 2020
Share Share
1ST Biotherapeutics and twoXAR Advance Three Novel Glioblastoma

1ST Biotherapeutics and twoXAR Advance Three Novel Glioblastoma
PR NEWSWIRE
25 Feb 2020
Share Share
SK Biopharmaceuticals and twoXAR Sign Collaboration Agreement to Discover and Develop First-In-Class Treatments for Non-Small Cell Lung Cancer

SK Biopharmaceuticals and twoXAR Sign Collaboration Agreement to Discover and Develop First-In-Class Treatments for Non-Small Cell Lung Cancer
BusinessWire
17 Apr 2019
Share Share
1ST Biotherapeutics, twoXAR Form Co-Development Collaboration for Glioblastoma

1ST Biotherapeutics, twoXAR Form Co-Development Collaboration for Glioblastoma
BUSINESSWIRE
03 Jan 2019
Share Share
TwoXar raises $10M from SoftBank, Andreessen Horowitz, & OS Fund its AI drug

TwoXar raises $10M from SoftBank, Andreessen Horowitz, & OS Fund its AI drug
VENTURE BEAT
19 Mar 2018
Share Share
A16z-backed twoXAR strikes software-driven drug discovery pact

A16z-backed twoXAR strikes software-driven drug discovery pact
Nick Paul Taylor FIERCE BIOTECH
27 May 2016
Share Share